审评服务送到“家门口”，药械审评检查京津冀分中心落地北京

Core Points - The establishment of the Beijing-Tianjin-Hebei Center marks a significant step in optimizing regional drug and medical device review services by the National Medical Products Administration [1][2] - The center aims to enhance collaboration in the pharmaceutical industry across the Beijing-Tianjin-Hebei region, leveraging existing resources and services to support innovation [2][3] Group 1: Center Operations - The Beijing-Tianjin-Hebei Center will provide comprehensive technical services including research guidance, consultation acceptance, and review communication for drug and medical device evaluations [2] - The center will connect the review and approval functions of Beijing with existing service institutions, creating a collaborative service network [2] Group 2: Industry Impact - The center aims to improve the efficiency and success rate of research and development for pharmaceutical companies by facilitating direct communication with experts [2] - Beijing's pharmaceutical and health industry has surpassed one trillion yuan, supported by numerous national research institutions and clinical resources [2] Group 3: Future Development - The center plans to establish a face-to-face consultation mechanism to assist companies in enhancing the quality of their research and applications [3] - Future collaboration between Beijing and the National Medical Products Administration will focus on creating a high-quality integrated development platform for the pharmaceutical industry [3]